Results

Total Results: 613 records

Showing results for "how to do a case study".

101. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
     March 15, 2005 - Unlike protective antibodies to other viruses, antibodies to HSV do not prevent local recurrences. … A culture may take 3 to 7 days to process. … However, data from reported cases do not represent a sufficient sample size for reaching reliable and … From KQ 1, a line goes to the left to "Screening" and a line/arrow proceeds to the right to the end outcomes … KQ 5-a is, "How effective are interventions in reducing symptomatic recurrences and transmission in adolescents

102. Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ERAa_Bwr7hQxqZZ-X3p8Qh
     May 10, 2022 - OBJECTIVE To conduct a targeted systematic review to update the evidence on the effectiveness of screening … STUDY SELECTION English-language studies of screening in individuals who do not recognize or report respiratory … against screening for COPD in asymptomatic adults (defined as individuals who do not recognize or report … suggest a clinically meaningful benefit in persons considered to be most applicable to a screen-detected … While no consistent benefit was seen among these trials it is unclear if and how small sample sizes,

103. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - populations; or (b) the differences in trial results are attributable to differences in how the trials … Second, we need to learn how best to use tamoxifen and raloxifene. … harmed, and better ways to counsel them about the effects of chemoprevention. 69 , 70 How many eligible … Whisnant JP, Wiebers DO, O'Fallon WM, Sicks JD, Frye RL. … Do chemopreventive agents have other beneficial effects?

104. Archived: Evidence Summary: Screening for Breast Cancer: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-breast-cancer/breast-cancer-screening-january-2016
     January 11, 2016 - breast cancer mortality, all-cause mortality, and advanced breast cancer for women at average risk; and how … screening in reducing breast cancer mortality, all-cause mortality, and advanced breast cancer, and how … included the most severe disease categories available from the trials, recognizing that these definitions do … on how cases were accrued in trials. … and conclusions in this document are those of the authors, who are responsible for its content, and do

105. Archived: Decision Analysis: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - For women aged 50 to 59 years with a 10-year CVD risk of 1% and both sexes aged 60 to 69 years with a … Our primary results do not find overall benefits to outweigh harms for persons in their 70s with a 10 … Aspirin primary prevention trials do not show a difference in GI bleeding mortality, but this may be … Better estimates of how age, sex, aspirin, and other possible risk factors interact to affect GI bleeding … Disclaimer: The views expressed in this article do not represent and should not be construed to represent

106. Archived: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening-2012
     March 15, 2012 - in women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade … Grade: A Do not screen. Grade: D Do not screen. Grade: D Do not screen. … Women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade … Finally, more research is needed to determine whether and how individual risk factors may be used to … which to end screening, and how often to screen.

107. Archived: Final Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan11/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
     December 15, 2012 - The figure illustrates how risk assessment for a BRCA mutation may result in classifying an individual … by women identified at increased risk for deleterious mutations who do not undergo genetic testing; … Genetic counseling = a service delivered by a qualified health professional that provides a comprehensive … by a nongenetics specialist in a clinical setting? … Do interventions reduce the incidence of BRCA-related cancer and mortality for women with increased risk

108. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pth_4-Mnau_pZubaefDvUk
     January 01, 2020 - Population: This reccommendation applies to asymptomatic women aged 40 years or older who do not have … (I statement) These recommendations apply to asymptomatic women aged 40 years or older who do not have … women aged ≥40 y who do not have preexisting breast cancer or a previously diagnosed high-risk breast … How Often to Screen Once a woman has decided to begin screening, the next decision is how often to undergo … overdiagnosis and how to dis- tinguish overdiagnosed cancer from cancer that is likely to progress,

109. Archived: Final Research Plan: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-in-older-adults-interventions-2018
     October 22, 2015 - Expand All Panel 1 The final Research Plan will be used to guide a systematic … How do included trials categorize participants as “high risk” for falls? … studies, including psychological outcomes KQ 1: Falls-related injuries other than fractures that do … comparable to a community-dwelling, primary care population (e.g., hospital, rehabilitation center, … Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe

110. Draft Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     April 25, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email … How do 10-year risk scores compare between the two models? … the degree to which the evidence is representative of diverse populations. … We will also include a Contextual Question to explore the limitations of existing cardiovascular disease … Criteria are overarching as well as specific to each of the Key Questions.

111. Recommendation: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening
     May 08, 2018 - Clinicians should not screen men who do not express a preference for screening. … Grade: C Do not screen for prostate cancer. … Clinicians should not screen men who do not express a preference for screening and should not routinely … national priority How to better inform men with a family history of prostate cancer about the benefits … to refine active prostate cancer treatments to minimize harms How to better understand patient values

112. Screening for Cervical Cancer: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-6kN7TPcfEj2owG4GTN2jA
     June 01, 2012 - removal of the cervix and who do not have a history of a high-grade precancerous lesion (cervical intraepithelial … removal of the cervix and who do not have a history of a high-grade precancerous lesion (cervical intraepithelial … Women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade … Finally, more research is needed to determine whether and how individual risk factors may be used to … which to end screening, and how often to screen.

113. Screening for Syphilis: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8L5g-QzXLDnUofBUE457DN
     July 01, 2004 - infectious syphilis because of unavailability of confirmatory tests.6 Also, nationally reported data do … A retrospective cohort analysis evaluated how placental pathology may contribute to the diagnosis of … However, there is a lack of data about how to identify high-risk groups. … a lack of well-designed trials to support this. … New studies do not contradict this evidence. References 1. U.S. Preventive Services Task Force.

114. Archived: Final Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan34/sexually-transmitted-infections-behavioral-counseling-september-2014
     May 15, 2013 - is used to guide a systematic review of the evidence by researchers at an Evidence-based Practice Center … The figure illustrates how behavioral counseling interventions to reduce sexually transmitted infections … Do behavioral counseling interventions to prevent STIs reduce risky sexual behaviors or increase protective … prevent or reduce STI/HIV (i.e., some provision of education, skills training, and guidance on how to … the health care system by the participant How delivered: To individuals or in small groups (15

115. Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R33bUm6oyjhWnbw96pJHwE
     April 01, 2009 - That lack of statistically significant effects, how- ever, may be a result of lack of power. … Thus, careful consideration must be given to how closely a patient will be able to be monitored, either … Preventive services in a health maintenance organization: how well do pediatricians screen and educate … Do antidepres- sants cause suicidality in children? A Bayesian meta-analysis. … reports; reports of expert committees A prediagnosis is made and reported a See reference 21. b See

116. Archived: Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/skin-cancer-screening-july-2016
     July 26, 2016 - Case series or case reports were also included for identification of potential harms due to screening … physician review of patient-identified lesions and likely do not represent screening populations. … Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary … Setting: Study was not conducted in a setting or country relevant to US primary care. … Fewer excisions were needed to detect a single case in older adults and in men.

117. Archived: Letter to the Editor and Response from the Evidence-Based Practice Center: Human Papillomavirus Testing to Screen for Cervical Cancer: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/letter-to-the-editor-and-response-from-the-evidence-based-practice-center--human-papillomavirus-testing-to-screen-for-cervical-cancer/cervical-cancer-screening-2012
     February 15, 2012 - Thus, judgment is required as to how trial and modeling results for cotesting apply in the United States … Thus, judgement is required as to how trial and modeling results for cotesting apply in the United States … How to evaluate emerging technologies in cervical cancer screening? … How might HPV testing be integrated into cervical screening? Lancet Oncol . 2012;13(1):8-10. 14. … When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we

118. Update on Methods: Insufficient Evidence | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/update-methods-insufficient-evidence
     March 04, 2021 - 2005 to consider how better to meet the needs of its constituents when evidence is insufficient. … For example, how bad is a "mild" stroke? … The USPSTF recognizes that these domains do not define the universe of domains applicable to clinical … How to read the new recommendation statement: methods update from the U.S. … How physicians approach prostate cancer screening before and after losing a lawsuit. 

119. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Aromatase inhibitors do not reduce, and may even increase, risk of fractures. … better understand how medications may reduce risk in these women. … Some examples are provided to help clinicians understand how to consider these risk factors, but these … How Does Evidence Fit With Biological Understanding? … What can I do to reduce my risk of breast cancer? CDC website.

120. Archived: Evidence Update: Prostate Cancer: Screening, 2008 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/article/prostate-cancer-screening-2008
     August 05, 2008 - Two poor-quality RCTs with important flaws in design and analysis ( Table 1 ) do not show a mortality … did not report information on the comparability of the groups, crossovers from the control group, or how … monitoring studies of highly selected older men with PSA-detected, nonpalpable, localized prostate cancer do … experiments    III: Opinions of respected authorities, based on clinical experience; descriptive studies or case … reports; reports of expert committees Design-specific criteria and quality category definitions